# BETH ISRAEL DEACONESS MEDICAL CENTER: A randomized trial of cardioprotective strategies in newly diagnosed diffuse large B-cell lymphoma and pre-existing cardiomyopathy or prior anthracycline exposure

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | BETH ISRAEL DEACONESS MEDICAL CENTER |
| Location | BOSTON, MA |
| Project | A randomized trial of cardioprotective strategies in newly diagnosed diffuse large B-cell lymphoma and pre-existing cardiomyopathy or prior anthracycline exposure |
| Project number | 5R37CA300969-02 |
| Mechanism | R37 |
| Institute | National Cancer Institute |
| Award | $706,054 |
| Awarded | 2026-09-14 |
| Project period | 2025-09-01 to 2030-08-31 |
| UEI | C1CPANL3EWK4 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11402640). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.